期刊文献+

多巴胺修饰超小Gd_2O_3纳米粒子的制备及MRI评价 被引量:1

Preparation and MRI Evaluation of Dopamine-Modified Ultra-Small Gd_2O_3 Nanoparticles
原文传递
导出
摘要 将具有邻苯二酚结构的多巴胺用于超小Gd2O3纳米粒子的表面修饰,通过控制反应时间,制得适用于磁共振成像(MRI)增强对比度的造影剂.通过透射电镜(TEM),红外光谱(FTIR),紫外-可见吸收光谱(UV-vis)及热重分析(TGA)测试表征了多巴胺修饰Gd2O3纳米粒子的形貌、结构及组成.结果表明:平均粒径为3.7nm的Gd2O3纳米粒子经多巴胺修饰后,由于多巴胺分子中苯环的疏水性导致了一定程度的聚集;反应12h和24h对应的多巴胺修饰的超小Gd2O3纳米粒子中有机物的组成分别为34.7%和42.6%.MRI造影结果显示,多巴胺表面修饰的超小Gd2O3纳米粒子有效地增强了对比亮度,且弛豫效率和信号强度在一定浓度范围内与造影剂浓度呈正相关;反应较长时间(24h)对应的多巴胺修饰的超小Gd2O3纳米粒子的弛豫效率较高,对应的造影增强效果更好. The dopamine with a catechol structure was used to modify ultra-small Gd2 03 nanoparticles (the diame- ter was lower than 5 nm), which produced the positive contrast enhanced agents for magnetic resonance imaging (MRI) by regulating the reaction time. The morphology, structure and composition of the as-prepared Gd2 03 nanop- articles were characterized by transmission electron microscope (TEM), Fourier transform infrared (FT-IR) spectros- copy, UV-vis spectroscopy and thermogravimel:ric analysis (TGA). By the TEM observation, the Gd2 03 nanoparti- cles with a mean diameter of ca. 3.7 nm tended[ to aggregate because of the hydrophobic benzene ring in dopamine. At the same time, the TGA results showed the dopamine-modified Gd2 03 nanoparticles for the reaction time of 12 and 24 hours had the weight percentage of organic components are 34. 7% and 42. 6%, respectively. Moreover, the T1- weighted MRI-related measurements were carried out for the dopamine-modified Gd2 03 nanoparticles. The results showed that the dopamine-modified Gd2O3 nanoparticles effectively enhanced the contrast brightness, and the relaxa- tion rates and signal intensity were positively correlated with the concentration of the contrast agent. A longer reaction time (24 hours) for the surface modification of dopamine toward ultra-small Gd2 03 nanoparticles contributed to higher relaxivity and better contrast enhancement effect thereof.
出处 《武汉大学学报(理学版)》 CAS CSCD 北大核心 2014年第4期305-310,共6页 Journal of Wuhan University:Natural Science Edition
基金 科技部国家国际科技合作专项项目(2013DFG32340)
关键词 超小Gd2O3纳米粒子 多巴胺 表面修饰 T1加权MRI增强 ultra-small Gd2O3 nanoparticles dopamine surface modification enhanced Zl-weighted MRI
  • 相关文献

参考文献25

  • 1Loai Y,Sakib N,Janik R,et al.Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7Tesla[J].Mol Imaging,2012,11(2):166-175.
  • 2Rudin M,Weissleder R.Molecular imaging in drug discovery and development[J].Nat Rev Drug Discov,2003,2(2):123-131.
  • 3Lauffer R B.Paramagnetic metal complexes as water proton relaxation agents for NMR imaging:Theory and design[J].Chem Rev,1987,87(5):901-927.
  • 4Caravan P,Ellison J J,Mcmurry T J,et al.Gadolinium(III)chelates as MRI contrast agents:Structure,dynamics,and applications[J].Chem Rev,1999,99(9):2293-2352.
  • 5Raymond K N,Pierre V C.Next generation,highrelaxivity gadolinium MRI agents[J].Bioconjugate Chem,2005,16(1):3-8.
  • 6Engstrm M,Klasson A,Pedersen H,et al.High proton relaxivity for gadolinium oxide nanoparticles[J].Magn Reson Mater Phys,Biol Med,2006,19(4):180-186.
  • 7Ahrén M,Selegrd L,Sderlind F,et al.A simple polyol-free synthesis route to Gd2O3nanoparticles for MRI applications:An experimental and theoretical study[J].J Nanopart Res,2012,14(8):1-17.
  • 8Mout R,Moyano D F,Rana S,et al.Surface functionalization of nanoparticles for nanomedicine[J].Chem Soc Rev,2012,41(7):2539-2544.
  • 9Laurent S,Forge D,Port M,et al.Magnetic iron oxide nanoparticles:Synthesis,stabilization,vectorization,physicochemical characterizations,and biological applications[J].Chem Rev,2008,108(6):2064-2110.
  • 10Ma W,Long Y T.Quinone/hydroquinone-functionalizedbiointerfaces for biological applications from the macro-to nano-scale[J].Chem Soc Rev,2013,43(1):30-41.

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部